Since 2020, Taiwan Food and Drug Administration has gradually released usage restrictions and labeling regulations for six new food raw materials produced from genetically modified microorganisms, including three 2′-fucosyllactose, astaxanthin, Ganoderma microsporum globulin-like protein concentrate, and trans-resveratrol. CIRS Group has compiled key information on these 6 products for industry reference.

On January 27, 2026, Taiwan released the “Guidelines for Safety Assessment of Novel Food Ingredients”, which clarify the definition, required submission materials, and regulatory procedures for novel food ingredients in Taiwan. The guidelines also specify documentation requirements for ingredients produced using genetically modified microorganisms (GMMs), ensuring the safety of such food ingredients for consumption.

In recent years, with the rapid improvement of social medical level and the living standard, Chinese consumers are paying close attention to health. Besides, the outbreak of coronavirus pandemic since the beginning of 2020 has made everyone become more aware of the importance of health and the pursuit of health has become more urgent. Therefore, health food with specific health functions and/or could regulate body functions have gradually become the focus of consumers.